ARCHIVES

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Blues Association, 2 cooperative Groups Form Pediatric Network

April 19, 1996

NCCS Networker Volume 8 Issue 2, Summer 1994

June 13, 1994

NCAB Urges Reprogramming If Needed To Assure $150 Million For Construction Through FY 1985

June 8, 1979

Bisphosphonates May Reduce Recurrent Breast Cancer

December 25, 2009

New Publications

January 20, 1989

In Brief: Surgeons Oncology Group Gets NCI Funding To Conduct Multicenter Clinical Trials

April 17, 1998